This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
India’s GLP-1 weight loss and diabetes drug market is at an inflection point. Cu...
IRDAI’s Bima Sugam: Easy, Commission-Free One-Stop Insurance App
Markets remain on edge after a sharp sell-off followed by a brief recovery, but ...
Amid rising crude oil prices and energy security concerns, India’s sugar industr...
India is finally witnessing the impact of rising global crude oil prices as prem...
Semaglutide went off patent in India on March 20, immediately drawing in generic...
India is facing a sharp surge in crude oil costs even as global benchmark Brent ...
The next generation of weight loss drugs is already in trials. Lilly's retatruti...
Long before he became a familiar face on screen, Norris had already made his mar...
Novo Nordisk India chief says GLP-1 adoption remains low and the market untappe...
Delayed joining letters and shrinking campus intakes point to a shift from bench...
Meanwhile, on Friday, Waaree Energies shares edged 0.25% higher at Rs 3164.20 ap...
WhatsApp is working on a significant update, as it will soon allow users to comm...
